日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Methyl-CpG-binding domain protein 2 epigenetically represses monocyte HLA-DR expression and promotes immune paralysis in HBV-related acute-on-chronic liver failure.

甲基-CpG结合域蛋白2通过表观遗传抑制单核细胞HLA-DR表达,促进HBV相关急性加慢性肝衰竭中的免疫麻痹。

Liu Xiaoqin, Jiang Xuhua, Zhang Xueyun, Hu Qiankun, Yu Xueping, Sun Jian, Lu Mingqin, Zhang Jiming, Huang Yuxian

HIF-1α/LTBP2 axis activate HSCs to promote liver fibrosis by interacting with LOXL1 via the ERK pathway.

HIF-1α/LTBP2 轴通过 ERK 通路与 LOXL1 相互作用激活 HSC,从而促进肝纤维化

Lu Mengxin, Tao Shuai, Zhao Conglin, Wang Neng, Hu Qiankun, Li Qiang, Qi Xun, Li Xinyan, Zhang Yi, Tu Chuantao, Huang Yuxian, Chen Liang

Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study

慢性乙型肝炎患者肝纤维化消退的非侵入性评估:一项回顾性队列研究

Xu, Wei; Hu, Qiankun; Chen, Chong; Li, Weixia; Li, Qiang; Chen, Liang

CHINAT-CD4 Score Predicts Transplant-Free Survival in Patients with Acute-on-Chronic Liver Failure

CHINAT-CD4评分可预测急性加重型慢性肝衰竭患者的无移植生存期

Huang, Chenlu; Li, Weixia; Chen, Chong; Xu, Wei; Fei, Ling; Tao, Shuai; Hu, Qiankun; Xie, Xudong; Cao, Xiongyue; Zhang, Xiao-Yu; Chen, Liang; Li, Qiang; Huang, Yuxian

FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort Study

FibroScan 可预测无明确抗病毒治疗指征的慢性乙型肝炎病毒感染患者的肝纤维化进展:一项回顾性队列研究

Xu, Wei; Hu, Qiankun; Chen, Chong; Li, Weixia; Li, Qiang; Chen, Liang

Noninvasive models for predicting poor prognosis of chronic HBV infection patients precipitating acute HEV infection

用于预测慢性乙型肝炎病毒感染患者发生急性戊型肝炎病毒感染预后不良的非侵入性模型

Li, Qiang; Chen, Chong; Huang, Chenlu; Xu, Wei; Hu, Qiankun; Chen, Liang